Top Markets
#1 DogBull DogBull +108.55%
#2 MarsCoin MarsCoin +76.65%
#3 Siacoin Siacoin +56.43%
#4 ADO Protocol ADO Protocol +52.50%
#5 Ontology Gas Ontology Gas +32.10%
#6 The Bitcoin Bull The Bitcoin Bull +30.29%
#7 Apertum Apertum +16.15%
#8 Pons Pons +13.49%
#9 Useless Coin Useless Coin +12.60%
#10 Stratis Stratis +12.32%
Coin of the day
DogBull DogBull
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Lexeo Therapeutics, Inc. Common Stock Lexeo Therapeutics, Inc. Common Stock

Lexeo Therapeutics, Inc. Common Stock

LXEO
Rang in Aktien #15117
Lexeo Therapeutics, Inc. is a genetic medicine firm currently in the clinical... Lexeo Therapeutics, Inc. is a genetic medicine firm currently in the clinical development phase, dedicated to addressing both inherited and acquired medical conditions. Its robust pipeline features several gene therapy candidates. These include LX2006, an AAVrh10-based therapy aimed at treating cardiomyopathy linked to Friedreich's ataxia (FA); LX2020, another AAVrh10-based candidate targeting arrhythmogenic cardiomyopathy; LX2021, designed for DSP cardiomyopathy; and LX2022, which focuses on hypertrophic cardiomyopathy (HCM) stemming from TNNI3 mutations. Furthermore, Lexeo is advancing LX1001, an AAVrh10-based gene therapy, alongside LX1020 and LX1021, all intended for individuals homozygous for APOE4. Additionally, LX1004 is under development to treat CLN2 Batten disease. Established in 2017, the company's headquarters are located in New York, New York.
Aktienkurs
$4.74
Zuletzt synchronisiert: 2026-08-31
Marktkapitalisierung
$372.19M
Veränderung (1 Tag)
-2.47%
Veränderung (1 Jahr)
-1.04%
Land
US
Handel Lexeo Therapeutics, Inc. Common Stock (LXEO)

Kategorie

Healthcare
Preis LXEO mit Marktkapitalisierung von B
Lexeo Therapeutics, Inc. Common Stock Lexeo Therapeutics, Inc. Common Stock
LXEO
$4.74
Marktkapitalisierung von Lexeo Therapeutics, Inc. Common Stock(LXEO)
Marktkapitalisierung: $372.19M
Mit Stand September 2026 hat Lexeo Therapeutics, Inc. Common Stock eine Marktkapitalisierung von $372.19M. Das macht Lexeo Therapeutics, Inc. Common Stock laut unseren Daten zum 15117th wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von Lexeo Therapeutics, Inc. Common Stock von 2023 bis 2026
LXEO im Vergleich zu den Top 5 der beliebtesten stocks
Preis für LXEO Vermögenswert B Marktkapitalisierung von B Ergebnisse
Lexeo Therapeutics, Inc. Common Stock Lexeo Therapeutics, Inc. Common Stock
$67,838.67 $372.19M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.327T +1,431,095.66%
Lexeo Therapeutics, Inc. Common Stock Lexeo Therapeutics, Inc. Common Stock
$59,154.10 $372.19M
Apple Inc. Apple Inc.
AAPL
$4.645T +1,247,876.74%
Lexeo Therapeutics, Inc. Common Stock Lexeo Therapeutics, Inc. Common Stock
$51,836.16 $372.19M
Alphabet Inc. Alphabet Inc.
GOOG
$4.070T +1,093,489.98%
Lexeo Therapeutics, Inc. Common Stock Lexeo Therapeutics, Inc. Common Stock
$48,197.93 $372.19M
Microsoft Corporation Microsoft Corporation
MSFT
$3.785T +1,016,733.97%
Lexeo Therapeutics, Inc. Common Stock Lexeo Therapeutics, Inc. Common Stock
$35,533.17 $372.19M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.790T +749,545.01%